Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Charles Soria

Showing results (1-10 of 475) with videos related to

Pageof 48
Sort By:
Bulletin Du Cancer|January 24, 2007
[Inhibitors of the EGFR pathway in non small cell lung cancer: what's new in 2007?]Julien Grenier, Jean-Charles Soria
Bulletin Du Cancer|June 4, 2013
[Discrepancies between primary tumor and metastasis: impact on personalized medicine]Stéphane Vignot, Jean-Charles Soria
Clinical Lung Cancer|March 5, 2010
The role of anti-epidermal growth factor receptor and anti-vascular endothelial growth factor therapies in the treatment of non-small-cell lung cancerCorey Langer, Jean-Charles Soria
Current Opinion in Oncology|January 21, 2015
Immune checkpoint inhibitors in advanced nonsmall cell lung cancerCarole Helissey, Stephane Champiat, Jean-Charles Soria
Journal of Nephrology|September 21, 2013
Proteinuria and VEGF-targeted therapies: 
an underestimated toxicity?Hassane Izzedine, Jean Charles Soria, Bernard Escudier
Current Opinion in Oncology|April 9, 2014
Implementing precision medicine initiatives in the clinic: a new paradigm in drug developmentAntoine Hollebecque, Christophe Massard, Jean-Charles Soria
Nature Reviews. Clinical Oncology|July 11, 2012
Tumour molecular profiling for deciding therapy-the French initiativeFrédérique Nowak, Jean-Charles Soria, Fabien Calvo
Nature Clinical Practice. Oncology|July 17, 2008
Mechanisms of Disease: signal transduction in lung carcinogenesis -- a comparison of smokers and never-smokersGiannis Mountzios, Pierre Fouret, Jean-Charles Soria
Current Opinion in Oncology|March 14, 2012
Vascular disrupting agents: a delicate balance between efficacy and side effectsAntoine Hollebecque, Christophe Massard, Jean-Charles Soria
Expert Review of Molecular Diagnostics|March 28, 2008
Gene expression profiling of non-small-cell lung cancerLudovic Lacroix, Frédéric Commo, Jean-Charles Soria
Pageof 48

Showing results (1-10 of 475) with videos related to

Sort By:
Pageof 48
Bulletin Du Cancer|January 24, 2007
[Inhibitors of the EGFR pathway in non small cell lung cancer: what's new in 2007?]Julien Grenier, Jean-Charles Soria
Bulletin Du Cancer|June 4, 2013
[Discrepancies between primary tumor and metastasis: impact on personalized medicine]Stéphane Vignot, Jean-Charles Soria
Clinical Lung Cancer|March 5, 2010
The role of anti-epidermal growth factor receptor and anti-vascular endothelial growth factor therapies in the treatment of non-small-cell lung cancerCorey Langer, Jean-Charles Soria
Current Opinion in Oncology|January 21, 2015
Immune checkpoint inhibitors in advanced nonsmall cell lung cancerCarole Helissey, Stephane Champiat, Jean-Charles Soria
Journal of Nephrology|September 21, 2013
Proteinuria and VEGF-targeted therapies: 
an underestimated toxicity?Hassane Izzedine, Jean Charles Soria, Bernard Escudier
Current Opinion in Oncology|April 9, 2014
Implementing precision medicine initiatives in the clinic: a new paradigm in drug developmentAntoine Hollebecque, Christophe Massard, Jean-Charles Soria
Nature Reviews. Clinical Oncology|July 11, 2012
Tumour molecular profiling for deciding therapy-the French initiativeFrédérique Nowak, Jean-Charles Soria, Fabien Calvo
Nature Clinical Practice. Oncology|July 17, 2008
Mechanisms of Disease: signal transduction in lung carcinogenesis -- a comparison of smokers and never-smokersGiannis Mountzios, Pierre Fouret, Jean-Charles Soria
Current Opinion in Oncology|March 14, 2012
Vascular disrupting agents: a delicate balance between efficacy and side effectsAntoine Hollebecque, Christophe Massard, Jean-Charles Soria
Expert Review of Molecular Diagnostics|March 28, 2008
Gene expression profiling of non-small-cell lung cancerLudovic Lacroix, Frédéric Commo, Jean-Charles Soria
Pageof 48